ZEOTOX – Botulinum Toxin Type A [South Korea]

ZEOTOX® – Botulinum Toxin Type A | High-Purity Export Toxin from South Korea

Product Overview

ZEOTOX® is a refined Botulinum Toxin Type A manufactured in South Korea, designed exclusively for overseas export markets. Produced under GMP-compliant conditions using modern purification techniques, ZEOTOX® provides consistent biological activity, clean diffusion, and stable potency—making it an attractive option for international buyers seeking a dependable botulinum toxin for non-clinical evaluation, comparative studies, or market testing.

While not registered for domestic use in Korea, ZEOTOX® is gaining global attention for its combination of high manufacturing quality and cost-effective positioning. This product is not intended for human or animal therapeutic use and is supplied strictly as an export-grade product.

---

Key Features & Advantages

• ✅ Manufactured in South Korea
  Produced in a GMP-certified facility with pharmaceutical-grade production protocols.

• ✅ Consistent Performance & Purity
  Reliable SNAP-25 cleavage activity, low protein impurity, and batch-to-batch consistency.

• ✅ Designed for Global Distribution
  Suitable for regulatory comparisons, technical validation, and scientific research models abroad.

• ✅ Controlled Diffusion Profile
  Effective in localized neuromuscular studies; minimizes unwanted spread in test systems.

• ✅ Export-Only Designation
  Not approved for domestic therapeutic use; exclusively supplied for authorized international partners.

---

Product Specifications

• Product Name: ZEOTOX® – Botulinum Toxin Type A

• Active Ingredient: Clostridium botulinum toxin type A

• Form: Lyophilized powder

• Strength: 100 Units / vial

• Appearance: White to off-white powder; forms clear solution when reconstituted

• Origin: South Korea

• Manufacturer: [Hugel]

• Storage: Store refrigerated at 2°C–8°C; use within 24 hours after reconstitution

• Classification: Export Use Only – Not approved for clinical or cosmetic use in Korea

---

Mechanism of Action

ZEOTOX® functions by selectively inhibiting the release of acetylcholine at the neuromuscular junction. Upon entry into cholinergic neurons, the toxin cleaves the SNAP-25 protein, a vital part of the SNARE complex required for vesicle fusion and neurotransmitter release.

This interruption leads to temporary localized muscle relaxation, and is widely used in experimental modeling of dynamic wrinkles, facial symmetry control, and neuromuscular modulation. ZEOTOX®’s purified structure enables clean response curves and low immunogenic potential, supporting precise comparative research.

For reference, see: NIH Mechanism Review

---

Use Cases in Export Markets

• Comparative testing vs. other botulinum toxin brands

• Non-clinical research into neuromodulation and SNAP-25 activity

• Distributor sampling and pre-market evaluation

• Institutional analysis and toxin registration support

• Market entry validation in emerging countries

---

Compliance Statement

This product is manufactured in South Korea and labeled exclusively for export use. It is not registered or approved for clinical, cosmetic, or therapeutic use within South Korea and must not be used for human or animal injection. All importers, distributors, and users are responsible for ensuring compliance with applicable regulations in their respective countries.

---

Tags / Keywords

ZEOTOX, Korean Botulinum Toxin, Botulinum Toxin Type A, Export-Only Toxin, GMP Neurotoxin Korea, SNAP-25 Inhibitor, Acetylcholine Blocker, Comparative Toxin Research, Botulinum for Distributors, Non-Clinical Botulinum

---

External References

• NIH: Botulinum Toxin Mechanism of Action

• WHO: Botulinum Toxin Fact Sheet

• PubMed Research on Botulinum Toxin A